首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >A platform analytical quality by design (AQbD) approach for multiple UHPLC-UV and UHPLC-MS methods development for protein analysis
【24h】

A platform analytical quality by design (AQbD) approach for multiple UHPLC-UV and UHPLC-MS methods development for protein analysis

机译:设计开发平台分析质量(AQbD)方法用于蛋白质分析的多种UHPLC-UV和UHPLC-MS方法开发

获取原文
获取原文并翻译 | 示例
           

摘要

A platform analytical quality by design approach for methods development is presented in this paper. This approach is not limited just to method development following the same logical analytical quality by design (AQbD) process, it is also exploited across a range of applications in methods development with commonality in equipment and procedures. As demonstrated by the development process of 3 methods, the systematic approach strategy offers a thorough understanding of the method scientific strength. The knowledge gained from the UHPLC-UV peptide mapping method can be easily transferred to the UHPLC-MS oxidation method and the UHPLC-UV C-terminal heterogeneity methods of the same protein. In addition, the platform AQbD method development strategy ensures method robustness is built in during development. In early phases, a good method can generate reliable data for product development allowing confident decision making. Methods generated following the AQbD approach have great potential for avoiding extensive post-approval analytical method change. While in the commercial phase, high quality data ensures timely data release, reduced regulatory risk, and lowered lab operational cost. Moreover, large, reliable database and knowledge gained during AQbD method development provide strong justifications during regulatory filling for the selection of important parameters or parameter change needs for method validation, and help to justify for removal of unnecessary tests used for product specifications. (C) 2016 Elsevier B.V. All rights reserved.
机译:本文提出了一种通过设计方法来分析质量的方法开发方法。这种方法不仅限于遵循相同的逻辑分析质量(AQbD)设计方法进行方法开发,而且还广泛用于方法开发中的各种应用程序中(在设备和过程中具有通用性)。正如3种方法的开发过程所证明的那样,系统的方法策略提供了对方法科学实力的透彻理解。从UHPLC-UV肽图分析方法获得的知识可以轻松地转移到同一蛋白质的UHPLC-MS氧化方法和UHPLC-UV C端异质性方法中。此外,平台AQbD方法开发策略可确保在开发过程中内置方法的鲁棒性。在早期阶段,一种好的方法可以为产品开发生成可靠的数据,从而做出可靠的决策。遵循AQbD方法生成的方法在避免大量批准后分析方法更改方面具有巨大潜力。在商业阶段,高质量的数据可确保及时发布数据,降低监管风险并降低实验室运营成本。此外,在AQbD方法开发过程中获得的庞大,可靠的数据库和知识为法规验证期间选择重要参数或参数更改需求进行方法验证提供了有力的依据,并有助于证明消除了用于产品规格的不必要测试的依据。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号